JACOB BALLON: Open Payments
NPI 1083835474 · PALO ALTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,029 in 24 payments from 5 companies in 2025. Trend: 2023 $13,756 · 2024 $10,475 · 2025 $3,029
Travel & lodging: $2,113Food & beverage: $805Education: $111
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $1,521 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $908 |
| E.R. Squibb & Sons, L.L.C. | 4 | $288 |
| Teva Pharmaceuticals USA, Inc. | 5 | $217 |
| Neurocrine BioSciences, Inc. | 2 | $95 |
Products named: ARISTADA, COBENFY, UZEDY, INGREZZA.
Industry payments across CA — which companies pay providers there.
